Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis

被引:0
|
作者
Kyle Fahrbach
Grammati Sarri
David M. Phillippo
Binod Neupane
Samantha E. Martel
Sandeep Kiri
Kristian Reich
机构
[1] Evidera (Evidence Synthesis),Bristol Medical School (Population Health Sciences)
[2] Evidera (Evidence Synthesis) The Ark,Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing
[3] University of Bristol,undefined
[4] UCB Pharma Ltd,undefined
[5] University Medical Center Hamburg-Eppendorf and Skinflammation® Center,undefined
来源
Dermatology and Therapy | 2021年 / 11卷
关键词
Biologic treatment; Efficacy; Network meta-analysis; Psoriasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1965 / 1998
页数:33
相关论文
共 50 条
  • [31] Biologic therapies targeting the interleukin (IL)-23/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis
    Erichsen, C. Y.
    Jensen, P.
    Kofoed, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : 30 - 38
  • [32] META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Hawkins, N. S.
    Huntley, A.
    Eaton, J.
    VALUE IN HEALTH, 2009, 12 (03) : A74 - A75
  • [33] SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS COMPARING NETAKIMAB WITH OTHER BIOLOGIC AGENTS USED TO TREAT ADULT PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN RUSSIA
    Tolkacheva, D.
    Sokolova, V
    Mladov, V
    VALUE IN HEALTH, 2019, 22 : S418 - S418
  • [34] Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
    Nast, Alexander
    Jacobs, Anja
    Rosumeck, Stefanie
    Werner, Ricardo N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (11) : 2641 - 2648
  • [35] Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year
    Yasmeen, Najeeda
    Sawyer, Laura M.
    Malottki, Kinga
    Levin, Lars-Ake
    Apol, Eydna Didriksen
    Jemec, Gregor B.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 204 - 218
  • [36] Indirect comparison of the short-, mid-, and long-term efficacy of treatments for moderate to severe plaque psoriasis: A systematic review and network meta-analysis
    Penas, Pablo Fernandez
    Armstrong, April W.
    Warren, Richard B.
    Zhong, Yichen
    Zhuo, Joe
    Cichewicz, Allie
    Kadambi, Ananth
    Junqueira, Daniela
    Westley, Tracy
    Kisa, Renata M.
    Daamen, Carolin
    Augustin, Matthias
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 23 - 23
  • [37] Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-analysis
    Xue, Weiguang
    Saharia, Paranjoy
    Gray, Emma
    Khoudigian-Sinani, Shoghag
    Gaudet, Veronique
    Barbeau, Martin
    Papp, Kim
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (06) : 561 - 572
  • [38] A NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF BRODALUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS
    Sawyer, L.
    Fotheringham, I
    Wright, E.
    Bermingham, S.
    Gibbons, C.
    Moller, A. H.
    Marques, R.
    VALUE IN HEALTH, 2017, 20 (09) : A801 - A801
  • [39] NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF IXEKIZUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS
    Hartz, S.
    Walzer, S.
    Dutronc, Y.
    Kiri, Himatlal S.
    Schacht, A.
    Dakin, H.
    VALUE IN HEALTH, 2016, 19 (07) : A576 - A576
  • [40] Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn's disease
    Su, Haohang
    Xiao, Shengwei
    Liang, Zhiqing
    Xun, Tianrong
    Zhang, Jinfang
    Yang, Xixiao
    FRONTIERS IN PHARMACOLOGY, 2025, 15